Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today it will be featured in HighRes’ Lightning Talk at the NVIDIA GTC AI ...

Overview Artificial intelligence seems to be transforming drug discovery in 2026, enabling faster molecule design, smarter clinical trials, and reduced R&D ...

Supercale launches automated advert creation with Shopify and Meta Ads connections, plus a confidence score for campaign iterations.

The resulting outcome is that you have A.I. systems that have learned what it means to solve a problem that takes quite a ...

On January 29, Chinese developer Qu Jiangfeng was using Antigravity AI, a product of Google DeepMind, to clean up project ...

IntroductionIn December 2025, Zscaler ThreatLabz discovered a campaign linked to APT37 (also known as ScarCruft, Ruby Sleet, and Velvet Chollima), which is a DPRK-backed threat group. In this campaign ...

Public Record Request Automation unlocks hard-to-access public records at scale. Customers define the data they need, and NationGraph handles the full request, extraction, and delivery process, ...

Korea 2026 is not just Korea of the early 2000s with taller buildings, faster internet, AI everywhere, more Dubai chocolate, ...

How is AI transforming medicine in 2026? From radiology to drug discovery to mental health apps — an honest look at what's real, what's hype, and what comes next.

VectorCertain's AIEOG Conformance Suite reveals that the Prevention Gap has a physical address: over 1.2 billion processors which process trillions of dollars daily with no on-device AI defense ...

Shares of Recursion Pharmaceuticals RXRX are surging Wednesday following a robust earnings report released before the bell.